| GTO ID | GTC2688 |
| Trial ID | NCT04888338 |
| Disease | Hematopoietic and Lymphoid Cell Neoplasm |
| Therapy | CAR-T cell |
| Treatment | CAR-T cells |
| Recruitment status | Recruiting |
| Title | Outcomes After Chimeric Antigen Receptor Therapy (CAR-T) and Radiation Therapy (RT) for Hematologic Malignancies |
| Year | 2021 |
| Country | United States |
| Company sponsor | M.D. Anderson Cancer Center |
| Other ID(s) | 2020-1150|NCI-2021-00910|2020-1150 |
| Cohort 1 | |||||||
|
|||||||